IQVIA’s eCOA Solution Receives 2020 Fierce Innovation Award
“We are honored to receive this prestigious award, which showcases outstanding innovation that is driving improvements and transforming the industry,” said
IQVIA eCOA is built on a highly secure, scalable SaaS platform that enables faster, flexible startup in clinical research and real world studies. IQVIA’s eCOA platform cuts up to three months from the industry standard eCOA development timeline while simultaneously improving the design through artificial intelligence-enabled design tools. This allows sponsors to launch trials faster and ensures the assessments will capture the right real-time insights to inform trial progress and demonstrate results.
IQVIA eCOA has a variety of capabilities that enhance the user experience and lead to time reductions, including a global library of pre-built assessments, which provides on-demand access to validated tools that can instantly be deployed. Currently, there are more than 850 assessments pre-configured in the library across a multitude of therapeutic areas.
The Fierce Innovation Awards go to companies that demonstrate innovative technologies and services with the potential to make the greatest impact for the life sciences industry. The awards program’s applications are reviewed by an exclusive panel of executives from major biotech and pharma companies. All honorees are evaluated based on effectiveness, technical innovation, competitive advantage, financial impact and true innovation.
Winners were announced in the 2020 Innovation Report published by
For more information on IQVIA eCOA, please visit https://www.iqvia.com/solutions/technologies/patient-engagement/ecoa.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Tor Constantino, IQVIA Media Relations (firstname.lastname@example.org)
Andrew Markwick, IQVIA Investor Relations (email@example.com)